Rivastigmine in the Treatment of Dementia: From the Symptomatic Effect to Neuroprotection
No Thumbnail Available
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Univer Publishing
Abstract
Description
Dementia is a hot topic today, largely as a result of the ageing of the population. One of the most common causes of dementia is Alzheimer's disease (AD). This disease, which is classified as a primary degenerative dementia, is characterized by a progressive decline in cognitive functions, primarily memory, and the development of behavioral disorders.
Keywords
dementia, mild cognitive impairment, treatment, rivastigmine